Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 8, 1997
has subject area
- 1103 Clinical Sciences (FoR)
- 1113 Opthalmology and Optometry (FoR)
- 1117 Public Health and Health Services (FoR)
- Acute Disease (MeSH)
- Anticoagulants (MeSH)
- Heparin (MeSH)
- Humans (MeSH)
- Patient Selection (MeSH)
- Plasminogen Activators (MeSH)
- Pulmonary Embolism (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Recombinant Proteins (MeSH)
- Recurrence (MeSH)
- Streptokinase (MeSH)
- Thrombolytic Therapy (MeSH)
- Tissue Plasminogen Activator (MeSH)
- Treatment Outcome (MeSH)
- Urokinase-Type Plasminogen Activator (MeSH)
published in
- JAMA Internal Medicine Journal